Skip to main content
. 2011 Jul 16;34(8):1838–1842. doi: 10.2337/dc11-0476

Table 2.

Baseline retinopathy status according to treatment group

Retinopathy status Placebo Enalapril/losartan
n 74 149
None (%) 27 (36.5) 49 (32.9)
Mild NPDR (%) 42 (56.8) 85 (57.0)
Moderate to severe NPDR (%) 5 (6.8) 15 (10.1)

NPDR, nonproliferative diabetic retinopathy.